Anhar Hassan1, E Ray Dorsey2, Christopher G Goetz3, Bastiaan R Bloem4, Mark Guttman5, Caroline M Tanner6,7, Zoltan Mari8,9, Alexander Pantelyat9, Nicholas B Galifianakis7, Jawad A Bajwa10, Emilia M Gatto11, Esther Cubo12. 1. 1 Department of Neurology, Mayo Clinic , Rochester, Minnesota. 2. 2 Department of Neurology, Center for Health + Technology, University of Rochester Medical Center , Rochester, New York. 3. 3 Department of Neurological Sciences, Rush University Medical Center , Chicago, Illinois. 4. 4 Department of Neurology, Radboud University Medical Center , Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands . 5. 5 Division of Neurology, Department of Medicine, University of Toronto , Toronto, Canada . 6. 6 Parkinson's Disease Research Education and Clinical Center, San Francisco Veteran's Affairs Medical Center , San Francisco, California. 7. 7 Department of Neurology, University of California San Francisco , San Francisco, California. 8. 8 Cleveland Clinic Lou Ruvo Center for Brain Health , Las Vegas, Nevada. 9. 9 Johns Hopkins University , Baltimore, Maryland. 10. 10 Parkinson's, Movement Disorders and Neurorestoration Program, National Neuroscience Institute , King Fahad Medical City, Riyadh, Saudi Arabia . 11. 11 Department of Neurology, Sanatorio de la Trinidad Mitre , Buenos Aires, Argentina . 12. 12 Servicio de Neurología, Hospital Universitario Burgos , Burgos, Spain .
Abstract
BACKGROUND: Telemedicine is increasingly used to care for patients with movement disorders, but data regarding its global use are limited. INTRODUCTION: To obtain baseline international data about telemedicine use among movement disorder clinicians. METHODS: An online survey was sent to all 6,056 Movement Disorder Society members in 2015. Scope, reimbursement, and perceived quality of telemedicine were assessed. RESULTS: There were 549 respondents (9.1% overall response rate) from 83 countries. Most (85.8%) were physicians, and most (70.9%) worked in an academic or university practice. Half of respondents (n = 287, from 57 countries) used telemedicine for clinical care; activities included e-mail (63.2%), video visits (follow-up [39.7%] and new [35.2%]), and video-based education (35.2%). One hundred five respondents personally conducted video visits, most frequently to outpatient clinics (53.5%), patient homes (30.8%), and hospital inpatients (30.3%). The most common challenges were a limited neurological examination (58.9%) and technological difficulties (53.3%), and the most common benefits were reduced travel time (92.9%) and patient costs (60.1%). The most frequent reimbursements were none (39.0%), public insurance (24.5%), and patient payment (9.3%). Half of respondents planned to use telemedicine in the future, and three-quarters were interested in telemedicine education. CONCLUSIONS: More than 250 respondents around the world engage in telemedicine for movement disorders; most perceived benefit for patients, despite challenges and reimbursement for clinicians. Formal instruction on telemedicine is highly desired. Although the survey response was low and possibly biased to over represent those with telemedicine experience, the study provides baseline data for future comparison and to improve telemedicine delivery.
BACKGROUND: Telemedicine is increasingly used to care for patients with movement disorders, but data regarding its global use are limited. INTRODUCTION: To obtain baseline international data about telemedicine use among movement disorder clinicians. METHODS: An online survey was sent to all 6,056 Movement Disorder Society members in 2015. Scope, reimbursement, and perceived quality of telemedicine were assessed. RESULTS: There were 549 respondents (9.1% overall response rate) from 83 countries. Most (85.8%) were physicians, and most (70.9%) worked in an academic or university practice. Half of respondents (n = 287, from 57 countries) used telemedicine for clinical care; activities included e-mail (63.2%), video visits (follow-up [39.7%] and new [35.2%]), and video-based education (35.2%). One hundred five respondents personally conducted video visits, most frequently to outpatient clinics (53.5%), patient homes (30.8%), and hospital inpatients (30.3%). The most common challenges were a limited neurological examination (58.9%) and technological difficulties (53.3%), and the most common benefits were reduced travel time (92.9%) and patient costs (60.1%). The most frequent reimbursements were none (39.0%), public insurance (24.5%), and patient payment (9.3%). Half of respondents planned to use telemedicine in the future, and three-quarters were interested in telemedicine education. CONCLUSIONS: More than 250 respondents around the world engage in telemedicine for movement disorders; most perceived benefit for patients, despite challenges and reimbursement for clinicians. Formal instruction on telemedicine is highly desired. Although the survey response was low and possibly biased to over represent those with telemedicine experience, the study provides baseline data for future comparison and to improve telemedicine delivery.
Authors: Samantha M R Kling; Jessica J Falco-Walter; Erika A Saliba-Gustafsson; Donn W Garvert; Cati G Brown-Johnson; Rebecca Miller-Kuhlmann; Jonathan G Shaw; Steven M Asch; Laurice Yang; Carl A Gold; Marcy Winget Journal: Neurol Clin Pract Date: 2021-12
Authors: Roy E Strowd; Lauren Strauss; Rachel Graham; Kristen Dodenhoff; Allysen Schreiber; Sharon Thomson; Alexander Ambrosini; Annie Madeline Thurman; Carly Olszewski; L Daniela Smith; Michael S Cartwright; Amy Guzik; Rebecca Erwin Wells; Heidi Munger Clary; John Malone; Mustapha Ezzeddine; Pamela W Duncan; Charles H Tegeler Journal: Neurol Clin Pract Date: 2021-06
Authors: Hanan Khalil; Lana M Chahine; Junaid Siddiqui; Mehri Salari; Shaimaa El-Jaafary; Zakiyah Aldaajani; Mishal Abu Al-Melh; Tareq Mohammad Mohammad; Muneer Abu Snineh; Nadir A Syed; Mohit Bhatt; Mohammad Ahsan Habib; Majed Habahbeh; Samer D Tabbal; Beomseok Jeon; Jawad A Bajwa Journal: J Parkinsons Dis Date: 2020 Impact factor: 5.568
Authors: Erika A Saliba-Gustafsson; Rebecca Miller-Kuhlmann; Samantha M R Kling; Donn W Garvert; Cati G Brown-Johnson; Anna Sophia Lestoquoy; Mae-Richelle Verano; Laurice Yang; Jessica Falco-Walter; Jonathan G Shaw; Steven M Asch; Carl A Gold; Marcy Winget Journal: J Med Internet Res Date: 2020-12-09 Impact factor: 5.428
Authors: Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe Journal: Front Neurol Date: 2021-07-01 Impact factor: 4.003